Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reports summarize breast cancer research from R.W. Mathes and co-authors
March 20th, 2008
According to a study from the United States, "Histamine(2)-receptor antagonist (H-2 blocker) medications are used to treat heartburn, gastroesophageal reflux disease, and ulcers. Some H-2 blockers, specifically cimetidine and ranitidine, also increase serum prolactin concentrations." "Given the positive relationship between prolactin levels and postmenopausal breast cancer risk, use of H-2 blockers is a potential breast cancer risk factor. The few previous studies evaluating this association have been null but have been limited by small sample sizes, and none have evaluated risk by either histologic type or estrogen receptor/progesterone receptor status. Combining data...
Source: Women's Health Weekly (2008-03-20)
|
